Nov 12, 2026
Musk Calls Claude Opus 5.5 a 'Masterpiece', Admits Grok 4.8 Falls Short
Elon Musk called Anthropic's Claude Opus 5.5 a 'masterpiece' and conceded Grok 4.8 won't match it, while xAI rebuilds its inference stack in C and C++. New Vercel data shows Opus 5.5 is the top model by paid spend among developers.
Nov 12, 2026
OpenAI Q3 Revenue Tops $10 Billion, But Losses Hit $10.9 Billion
OpenAI crossed $10 billion in quarterly revenue for the first time, up 50% from Q2, but its operating loss hit $10.9 billion. The loss-per-dollar figure fell to $1.09, even as rival Anthropic posted $17 billion in revenue with a fraction of the losses.
Nov 12, 2026
Anthropic IPO Is 'Multiple Times Oversubscribed' as Roadshow Begins
Anthropic's roadshow kicked off with massive demand as the Claude maker's IPO is already multiple times oversubscribed, raising up to $90.4 billion at a $1.4 trillion valuation. Claude traffic surged 24% in October as the company heads toward a November 19 Nasdaq debut.
Related News
Oct 29, 2026
Pew’s healthcare AI survey separates human review from autonomous use
Pew’s October 29 report distinguishes AI working alone from final human review. Its task questions went to 1,751 respondents within a larger U.S. adult survey.
Oct 29, 2026
Anthropic’s expanded science credits follow different research-access routes
Anthropic’s October 28 expansion distributes Claude credits through funders, inside research institutions and directly to specific initiatives. Researchers need to identify which route can support their project.
Oct 28, 2026
Anthropic outlines six drug-development partnerships and in-house Mithril work
Anthropic’s October 27 update separates external research collaborations from Mithril Medicine work now inside the company. It describes early research involvement, not an acquisition closing date or a clinical result.